Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 964178, 10 pages
http://dx.doi.org/10.1155/2015/964178
Research Article

Specific Proteins in Nontuberculous Mycobacteria: New Potential Tools

1Programa de Inmunología Molecular Microbiana, Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 Mexico City, DF, Mexico
2División de Investigación Clínica, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510 Mexico City, DF, Mexico

Received 25 October 2014; Revised 20 December 2014; Accepted 21 December 2014

Academic Editor: Mehdi Mirsaeidi

Copyright © 2015 Patricia Orduña et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. O. Falkinham III, “Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment,” Journal of Applied Microbiology, vol. 107, no. 2, pp. 356–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. I. Castillo-Rodal, M. Mazari-Hiriart, L. T. Lloret-Sánchez, B. Sachman-Ruiz, P. Vinuesa, and Y. López-Vidal, “Potentially pathogenic nontuberculous mycobacteria found in aquatic systems. Analysis from a reclaimed water and water distribution system in Mexico City,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 5, pp. 683–694, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. M. Thomson, “Changing epidemiology of pulmonary nontuberculous mycobacteria infections,” Emerging Infectious Diseases, vol. 16, no. 10, pp. 1576–1583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. P. M. Cassidy, K. Hedberg, A. Saulson, E. McNelly, and K. L. Winthrop, “Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology,” Clinical Infectious Diseases, vol. 49, no. 12, pp. e124–e129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. B. M. Knoll, “Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients,” Current Infectious Disease Reports, vol. 16, no. 9, article 421, 2014. View at Publisher · View at Google Scholar
  6. E. E. Bodle, J. A. Cunningham, P. Della-Latta, N. W. Schluger, and L. Saiman, “Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City,” Emerging Infectious Diseases, vol. 14, no. 3, pp. 390–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. I. M. Orme and D. J. Ordway, “Host response to nontuberculous mycobacterial infections of current clinical importance,” Infection and Immunity, vol. 82, no. 9, pp. 3516–3522, 2014. View at Publisher · View at Google Scholar
  8. J. Esteban, N. Z. Martín-de-Hijas, A.-I. Fernandez, R. Fernandez-Roblas, and I. Gadea, “Epidemiology of infections due to nonpigmented rapidly growing mycobacteria diagnosed in an urban area,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 27, no. 10, pp. 951–957, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. M. Vaerewijck, G. Huys, J. C. Palomino, J. Swings, and F. Portaels, “Mycobacteria in drinking water distribution systems: ecology and significance for human health,” FEMS Microbiology Reviews, vol. 29, no. 5, pp. 911–934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. G. Shelton, W. D. Flanders, and G. K. Morris, “Mycobacterium sp. as a possible cause of hypersensitivity pneumonitis in machine workers,” Emerging Infectious Diseases, vol. 5, no. 2, pp. 270–273, 1999. View at Google Scholar
  11. WHO, “BCG vaccine,” Weekly Epidemiological Record 4, 2004. View at Google Scholar
  12. P. Andersen and T. M. Doherty, “The success and failure of BCG—implications for a novel tuberculosis vaccine,” Nature Reviews Microbiology, vol. 3, no. 8, pp. 656–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. F. Black, H. M. Dockrell, A. C. Crampin et al., “Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in Northern Malawi,” Journal of Infectious Diseases, vol. 184, no. 3, pp. 322–329, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Demangel, T. Garnier, I. Rosenkrands, and S. T. Cole, “Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens,” Infection and Immunity, vol. 73, no. 4, pp. 2190–2196, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Brandt, J. F. Cunha, A. W. Olsen et al., “Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis,” Infection and Immunity, vol. 70, no. 2, pp. 672–678, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Mendoza-Coronel, R. Camacho-Sandoval, L. C. Bonifaz, and Y. López-Vidal, “PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response,” Tuberculosis, vol. 91, no. 1, pp. 36–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Kröger, M. Korppi, J. Pelkonen, M. Pietikäinen, and M. L. Katila, “Development of tuberculin reactivity and sensitization to M. scrofulaceum and M. fortuitum in children BCG-vaccinated at birth,” European Respiratory Journal, vol. 15, no. 2, pp. 382–387, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. B. L. Marmorstein and D. J. Scheinhorn, “The role of nontuberculous mycobacterial skin test antigens in the diagnosis of mycobacterial infections,” Chest, vol. 67, no. 3, pp. 320–324, 1975. View at Publisher · View at Google Scholar · View at Scopus
  19. R. E. Huebner, M. F. Schein, G. M. Cauthen et al., “Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses,” The American Review of Respiratory Disease, vol. 145, no. 5, pp. 1160–1166, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pai, “Alternatives to the tuberculin skin test: Interferon-γ assays in the diagnosis of Mycobacterium tuberculosis infection,” Indian Journal of Medical Microbiology, vol. 23, no. 3, pp. 151–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Rodríguez-Alvarez, G. Mendoza-Hernández, S. Encarnación, J. J. Calva, and Y. López-Vidal, “Phenotypic differences between BCG vaccines at the proteome level,” Tuberculosis, vol. 89, no. 2, pp. 126–135, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Rodríguez-Alvarez, I. D. Palomec-Nava, G. Mendoza-Hernández, and Y. López-Vidal, “The secretome of a recombinant BCG substrain reveals differences in hypothetical proteins,” Vaccine, vol. 28, no. 23, pp. 3997–4001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Rosenkrands, K. Weldingh, S. Jacobsen et al., “Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection,” Electrophoresis, vol. 21, no. 5, pp. 935–948, 2000. View at Publisher · View at Google Scholar
  24. Y. Y. Bahk, S. A. Kim, J. S. Kim et al., “Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker,” Proteomics, vol. 4, no. 11, pp. 3299–3307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Proteome 2D-PAGE Database, http://web.mpiib-berlin.mpg.de/cgi-bin/pdbs/2d-page/extern/index.cgi.
  26. S. Borsuk, J. Newcombe, T. A. Mendum, O. A. Dellagostin, and J. McFadden, “Identification of proteins from tuberculin purified protein derivative (PPD) by LC-MS/MS,” Tuberculosis, vol. 89, no. 6, pp. 423–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Orduña, M. A. Cevallos, S. P. De León et al., “Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection,” BMC Genomics, vol. 12, article 493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Kitaura, M. Kinomoto, and T. Yamada, “Ribosomal protein L7 included in tuberculin purified protein derivative (PPD) is a major heat-resistant protein inducing strong delayed-type hypersensitivity,” Scandinavian Journal of Immunology, vol. 50, no. 6, pp. 580–587, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kim, H. Sohn, J.-S. Kim et al., “Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway,” Immunology, vol. 136, no. 2, pp. 231–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W.-X. Xu, L. Zhang, J.-T. Mai et al., “The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis,” Biochemical and Biophysical Research Communications, vol. 448, no. 3, pp. 255–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. M. K. Gupta, V. Subramanian, and J. S. Yadav, “Immunoproteomic identification of secretory and subcellular protein antigens and functional evaluation of the secretome fraction of Mycobacterium immunogenum a newly recognized species of the Mycobacterium chelonaeMycobacterium abscessus group,” Journal of Proteome Research, vol. 8, no. 5, pp. 2319–2330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Dong, S. Demaria, X. Sun et al., “HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase,” Infection and Immunity, vol. 72, no. 4, pp. 2412–2415, 2004. View at Google Scholar
  33. L. M. van den Berg, S. I. Gringhuis, and T. B. H. Geijtenbeek, “An evolutionary perspective on C-type lectins in infection and immunity,” Annals of the New York Academy of Sciences, vol. 1253, no. 1, pp. 149–158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. K. K. Huynh, S. A. Joshi, and E. J. Brown, “A delicate dance: host response to mycobacteria,” Current Opinion in Immunology, vol. 23, no. 4, pp. 464–472, 2011. View at Publisher · View at Google Scholar · View at Scopus